Long-Term PM2.5 Exposure Linked to Increased Risk of Nasal Polyps in Chronic Rhinosinusitis: Study Finds

Written By :  Medha Baranwal
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2025-05-01 15:00 GMT   |   Update On 2025-05-01 15:00 GMT
Advertisement

USA: In a recent exposure-matched study, researchers found that long-term exposure to fine particulate matter (PM2.5) may significantly increase the risk of developing chronic rhinosinusitis with nasal polyposis (CRSwNP), highlighting the potential role of air pollution in upper airway inflammatory diseases.

The analysis, published in the International Forum of Allergy & Rhinology, revealed that individuals with higher PM2.5 exposure had over seven times greater odds of developing CRSwNP (OR 7.22). Additionally, control participants exposed to elevated PM2.5 levels exhibited reduced interleukin-10 (IL-10) levels (β −0.735), a key anti-inflammatory cytokine. Interestingly, this association was not observed in patients with CRS without nasal polyps, suggesting a possible specific link between PM2.5 exposure and the development of nasal polyps.

Advertisement

Particulate matter ≤2.5 µm in diameter has emerged as a potential contributor to chronic rhinosinusitis (CRS) by promoting upper airway inflammation. Prior studies have indicated that PM2.5 exposure may shift the nasal mucosa toward a Type 2 inflammatory response, commonly seen in CRS with nasal polyposis (CRSwNP).

Building on this, Naweed I. Chowdhury from the Department of Otolaryngology—Head and Neck Surgery at University of Alabama at Birmingham, Birmingham, AL, and colleagues explored whether long-term PM2.5 exposure is specifically linked to CRSwNP rather than non-polyp CRS. With limited comparative data on cytokine changes in CRS and non-CRS patients, the study hypothesized that chronic exposure may selectively increase the risk of polyp formation.

For this purpose, the researchers analyzed data from 376 patients (308 with CRS and 68 controls) who underwent sinus or skull base surgery. A machine-learning model estimated daily PM2.5 exposure for the year before surgery. Cytokine levels were measured and correlated with PM2.5 exposure using Spearman and multivariate analyses. High- and low-exposure groups were matched by age, sex, income, and rurality. Logistic regression was used to assess the odds of CRS based on PM2.5 exposure.

The key findings of the study were as follows:

  • Higher PM2.5 exposure was significantly associated with reduced IL-10 levels in control patients (β = −0.735).
  • In the exposure-matched logistic regression analysis, elevated 12-month PM2.5 exposure independently predicted CRSwNP (β = 1.97, OR: 7.22) after adjusting for age, income, rurality, and comorbid asthma/allergic rhinitis.
  • There was no significant association between PM2.5 exposure and CRSsNP.

The findings reinforce the role of PM2.5 as an independent risk factor for developing chronic rhinosinusitis with nasal polyposis, with the associated risk comparable to that posed by comorbid asthma or allergic rhinitis. Notably, reduced levels of IL-10—a key anti-inflammatory cytokine—were observed in control patients exposed to higher levels of PM2.5, suggesting a potential mechanistic link between prolonged particulate matter exposure and increased vulnerability to nasal mucosal inflammation.

"While these findings highlight a possible pathway contributing to CRSwNP, further validation through experimental, in vitro, and longitudinal multi-omics studies is warranted," the authors concluded.

Reference:

Lubner, R. J., Krysinski, M., Li, P., Chandra, R. K., Turner, J. H., & Chowdhury, N. I. Long-Term Particulate Matter Exposure May Increase Risk of Chronic Rhinosinusitis WIth Nasal Polyposis: Results from an Exposure-Matched Study. International Forum of Allergy & Rhinology, e23589. https://doi.org/10.1002/alr.23589


Tags:    
Article Source : International Forum of Allergy & Rhinology

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News